MANIAN BALA S 4
4 · VACCINEX, INC. · Filed May 15, 2023
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
MANIAN BALA S
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-11+143,848→ 143,848 totalExercise: $0.41From: 2024-05-11→ Common Stock (143,848 underlying)
Holdings
- 7,718
Stock Option (Right to Buy)
Exercise: $7.78From: 2020-05-15→ Common Stock (7,718 underlying) - 15,679
Stock Option (Right to Buy)
Exercise: $3.95From: 2021-05-14→ Common Stock (15,679 underlying) - 28,586
Stock Option (Right to Buy)
Exercise: $2.15From: 2022-05-11→ Common Stock (28,586 underlying) - 53,254
Stock Option (Right to Buy)
Exercise: $1.12From: 2023-05-12→ Common Stock (53,254 underlying)
Footnotes (5)
- [F1]This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
- [F2]This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
- [F3]This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
- [F4]This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
- [F5]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.